TGFB1 and acute myeloid leukemia: In the context of hematological disorders, such as AML, TGF-β can act both as a tumor suppressor, due to its role in cell proliferation and apoptosis, but also as a tumor promoter because of its effects on migration and downregulation of effective immune responses [106].